Our pipeline shows our relentless pursuit of the next breakthrough. Explore our pipeline Phase II programs 80+ Phase III programs 30+ Under review 10+ Our leadership Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy. ...
The Phase 1 double-blind, placebo-controlled trial evaluated the safety, tolerability and PK of islatravir administered using a drug-eluting implant placed subdermally in healthy participants. People in the study received an implant containin...
Acceleron has expanded its rare pulmonary disease pipeline and is investigating the potential of ACE-1334 in a Phase 1b/Phase 2 trial in systemic sclerosis-associated interstitial lung disease (SSc-ILD). In hematology, REBLOZYL (luspatercept-aamt) is the first and only erythroid maturation ...
Phase 1 Questions it may answer: Is the treatment safe? How much of it is needed? Are there any side effects? Who takes part: A small group (about 20 to 100) of usually healthy people How long it takes: 6 months to 1 year Phase 2 Questions it may answer: How well does the ...
Pipeline drugs may fail to deliver before patent expiry of Keytruda in 2028.When Keytruda inevitably loses its patent in 2028, it would lose exclusivity and face fierce competition. Merck may not see its pipeline drugs launch by then, and may face risk of revenue drops. ...
of BAVENCIO first-line (1L) maintenance and further support its use as a standard of care for advanced UC. As part of the JAVELIN Bladder regimen, BAVENCIO first-line maintenance has demonstrated the longest survival benefit seen to date in a global, randomized Phase III trial in advanced UC...
Merck made important advancements in its broad, diverse pipeline, meeting significant regulatory and clinical milestones throughout the fourth quarter. In oncology, Merck announced positive topline results from the pivotal Phase 3 MK-3475A-D77 trial evaluating the noninferiority of subcutaneous pembrolizu...
Merck & Co is to buy US biotech OncoImmune for at least $425m, adding a potential new therapy for COVID-19 to its pipeline.
to ISO14001, water risks are identified and assessed as approval phase (e.g., (c) Investors BECAUSE an ad hoc process. Risks below these thresholds are steered independently environmental aspects. We use the water risk factor derived by the WRI under REACH) or (b) their decisions depend ...
Merck made important advancements in its broad, diverse pipeline, meeting significant regulatory and clinical milestones throughout the fourth quarter. In oncology, Merck announced positive topline results from the pivotal Phase 3 MK-3475A-D77 trial evaluating the noninferiority of subcutaneous pembrolizu...